Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Floor J Backes

Showing results (81-90 of 110) with videos related to

Pageof 11
Sort By:
Journal of Minimally Invasive Gynecology|January 19, 2016
A Prospective, Comparative Study for the Evaluation of Postoperative Pain and Quality of Recovery in Patients Undergoing Robotic Versus Open Hysterectomy for Staging of Endometrial CancerDavid E Cohn, Karina Castellon-Larios, Laura Huffman, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for uterine serous carcinomaSatoru Sagae, Nobuyuki Susumu, Akila N Viswanathan, et al.
Gynecologic Oncology|June 1, 2025
The impact of antibiotics, proton pump inhibitors, H2-receptor antagonists, and steroids on survival in ovarian cancer patients receiving PARP inhibitor therapyQuinn Kistenfeger, Paulina J Haight, Monica Levine, et al.
Gynecologic Oncology|September 23, 2023
The impact of antibiotic and proton pump inhibitor use at the time of adjuvant platinum-based chemotherapy on survival in patients with endometrial cancerPaulina J Haight, Quinn Kistenfeger, Courtney J Riedinger, et al.
Future Oncology (London, England)|July 31, 2024
Maintenance with mirvetuximab soravtansine plus bevacizumab vs bevacizumab in FRα-high platinum-sensitive ovarian cancerDavid M O'Malley, Tashanna Myers, Pauline Wimberger, et al.
Plos One|June 29, 2023
Expression of microRNAs and their target genes in melanomas originating from gynecologic sitesMallory J DiVincenzo, Colin D Angell, Lorena P Suarez-Kelly, et al.
Gynecologic Oncology|January 23, 2024
Does the choice of platinum doublet matter? A study to evaluate the impact of platinum doublet choice for treatment of platinum-sensitive ovarian cancer recurrence on the development of future PARP inhibitor and platinum resistanceMonica D Levine, Heather Wang, Bhargavi Sriram, et al.
Neoplasia (New York, N.Y.)|August 21, 2020
Evaluating the efficacy of enzalutamide and the development of resistance in a preclinical mouse model of type-I endometrial carcinomaChristopher S Koivisto, Melodie Parrish, Santosh B Bonala, et al.
Surgical Oncology|September 6, 2020
Pathologic chemotherapy response score in epithelial ovarian cancer: Surgical, genetic, and survival considerationsDavid A Barrington, Ashley S Felix, Rieham Owda, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 10, 2012
Performance of PREMM(1,2,6), MMRpredict, and MMRpro in detecting Lynch syndrome among endometrial cancer casesRowena C Mercado, Heather Hampel, Fay Kastrinos, et al.
Pageof 11

Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
Journal of Minimally Invasive Gynecology|January 19, 2016
A Prospective, Comparative Study for the Evaluation of Postoperative Pain and Quality of Recovery in Patients Undergoing Robotic Versus Open Hysterectomy for Staging of Endometrial CancerDavid E Cohn, Karina Castellon-Larios, Laura Huffman, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for uterine serous carcinomaSatoru Sagae, Nobuyuki Susumu, Akila N Viswanathan, et al.
Gynecologic Oncology|June 1, 2025
The impact of antibiotics, proton pump inhibitors, H2-receptor antagonists, and steroids on survival in ovarian cancer patients receiving PARP inhibitor therapyQuinn Kistenfeger, Paulina J Haight, Monica Levine, et al.
Gynecologic Oncology|September 23, 2023
The impact of antibiotic and proton pump inhibitor use at the time of adjuvant platinum-based chemotherapy on survival in patients with endometrial cancerPaulina J Haight, Quinn Kistenfeger, Courtney J Riedinger, et al.
Future Oncology (London, England)|July 31, 2024
Maintenance with mirvetuximab soravtansine plus bevacizumab vs bevacizumab in FRα-high platinum-sensitive ovarian cancerDavid M O'Malley, Tashanna Myers, Pauline Wimberger, et al.
Plos One|June 29, 2023
Expression of microRNAs and their target genes in melanomas originating from gynecologic sitesMallory J DiVincenzo, Colin D Angell, Lorena P Suarez-Kelly, et al.
Gynecologic Oncology|January 23, 2024
Does the choice of platinum doublet matter? A study to evaluate the impact of platinum doublet choice for treatment of platinum-sensitive ovarian cancer recurrence on the development of future PARP inhibitor and platinum resistanceMonica D Levine, Heather Wang, Bhargavi Sriram, et al.
Neoplasia (New York, N.Y.)|August 21, 2020
Evaluating the efficacy of enzalutamide and the development of resistance in a preclinical mouse model of type-I endometrial carcinomaChristopher S Koivisto, Melodie Parrish, Santosh B Bonala, et al.
Surgical Oncology|September 6, 2020
Pathologic chemotherapy response score in epithelial ovarian cancer: Surgical, genetic, and survival considerationsDavid A Barrington, Ashley S Felix, Rieham Owda, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 10, 2012
Performance of PREMM(1,2,6), MMRpredict, and MMRpro in detecting Lynch syndrome among endometrial cancer casesRowena C Mercado, Heather Hampel, Fay Kastrinos, et al.
Pageof 11